A Study of the Efficacy and Safety of Tocilizumab in Participants With Systemic Sclerosis (SSc)

NCT02453256 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

212

Enrollment

INDUSTRY

Sponsor class

Conditions

Systemic Sclerosis

Interventions

DRUG: Placebo
DRUG: Tocilizumab

Sponsor

Hoffmann-La Roche